Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

BMS 309403

Name BMS 309403
Supplier R&D Systems
Catalog 5258
Prices $139.00, $585.00
Sizes 10 mg, 50 mg
Cas Number 300657-03-8
Chemical Name 2-[[2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)[1,1'-biphenyl]-3-yl]oxy]-aceticacid
Formula C31H26N2O3
Molecular Weight 474.55
Purity >98%
Supplier Page Shop

Product References

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding - Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding

Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS. Nature. 2007 Jun 21;447(7147):959-65. Epub 2007 Jun 6.

Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding - Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding

Sulsky R, Magnin DR, Huang Y, Simpkins L, Taunk P, Patel M, Zhu Y, Stouch TR, Bassolino-Klimas D, Parker R, Harrity T, Stoffel R, Taylor DS, Lavoie TB, Kish K, Jacobson BL, Sheriff S, Adam LP, Ewing WR, Robl JA. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3511-5. Epub 2006 Dec 21.

BMS309403 stimulates glucose uptake in myotubes through activation of - BMS309403 stimulates glucose uptake in myotubes through activation of

Lin W, Huang X, Zhang L, Chen D, Wang D, Peng Q, Xu L, Li J, Liu X, Li K, Ding K, Jin S, Li J, Wu D. PLoS One. 2012;7(8):e44570.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved